Process steps for the fractionation of immunoglobulin (Ig) G depleted of IgA, isoagglutinins, and devoid of in vitro thrombogenicity.

Saved in:
Bibliographic Details
Title: Process steps for the fractionation of immunoglobulin (Ig) G depleted of IgA, isoagglutinins, and devoid of in vitro thrombogenicity.
Authors: Cheng JH; Merck Ltd, Taiwan., Wu YW; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Wang CY; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Wu SS; Merck Ltd, Taiwan., Hong CL; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Chan KW; Merck Pte Ltd, Singapore., Liao LX; Merck Chemicals (Shanghai) Co. Ltd, China., Cao X; Merck Chemicals (Shanghai) Co. Ltd, China., Wang B; Merck Chemicals (Shanghai) Co. Ltd, China., Burnouf T; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
Source: Blood transfusion = Trasfusione del sangue [Blood Transfus] 2021 Nov; Vol. 19 (6), pp. 467-478. Date of Electronic Publication: 2021 Aug 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SIMTI servizi Country of Publication: Italy NLM ID: 101237479 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2385-2070 (Electronic) Linking ISSN: 17232007 NLM ISO Abbreviation: Blood Transfus Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2385-2070
DOI:10.2450/2021.0159-21